Overall market sentiment has been neutral on Arca Biopharma Inc (ABIO) stock lately. ABIO receives a ABIO rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With ABIO Stock Today?
Arca Biopharma Inc (ABIO) stock has fallen -2.45% while the S&P 500 has risen 0.12% as of 12:51 PM on Friday, Feb 12. ABIO is down -$0.13 from the previous closing price of $5.30 on volume of 987,207 shares. Over the past year the S&P 500 is higher by 16.03% while ABIO is down -5.83%. ABIO lost -$2.65 per share in the over the last 12 months.
More About Arca Biopharma Inc
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.